Clinical Trial: Quantification of Change in MG Disease Activity in Individuals With Generalized Myasthenia Gravis (gMG) After Administration of VYVGART(R) or VYVGART Hytrulo(R) Using BioDigit MG

U.S., Nov. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07226830) titled 'Quantification of Change in MG Disease Activity in Individuals With Generalized Myasthenia Gravis (gMG) After Administration of VYVGART(R) or VYVGART Hytrulo(R) Using BioDigit MG' on Nov. 07.

Brief Summary: Evaluate the feasibility of using digital health technologies to monitor disease symptoms over time in individuals with gMG who are initiating treatment with VYVGART(R) or VYVGART Hytrulo(R).

Study subjects will be screened and enrolled at Massachusetts General Brigham Hospital to participate in this 16 week observational study.

Study subjects will be asked to wear multiple wearable sensors to monitor their physical activity an...